Evidence map›Paper›PMID 23093402›Full record

ArticleThe Journal of biological chemistry2012

Heme-assisted S-nitrosation desensitizes ferric soluble guanylate cyclase to nitric oxide.

Nathaniel B Fernhoff, Emily R Derbyshire, Eric S Underbakke, Michael A Marletta

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Key roles of GAPDH, Hsp90, and NO in heme trafficking.Journal of inorganic biochemistry · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nathaniel B FernhoffDepartment of Molecular and Cell Biology, University of California, Berkeley, California 94720, USA.
Emily R Derbyshire
Eric S Underbakke
Michael A Marletta
University of California, Berkeley · USScripps Research Institute · US

Funding

Univ of Calif Berkeley Chemistry-Biology Interface ProgramT32GM066698 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI CHANG, CHRISTOPHER J., FRANCIS, MATTHEW B · 2004 to 2023
$7.5M
Nitric Oxide Signaling And Soluble Guanylate CyclaseR01GM077365 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI MARLETTA, MICHAEL A. · 2007 to 2010
$1.0M
NIGMS NIH HHS GM077365.NIGMS NIH HHS R01 GM077365NIGMS NIH HHS T32 GM066698
6 · The paper itself

Abstract

Nitric oxide (NO) signaling regulates key processes in cardiovascular physiology, specifically vasodilation, platelet aggregation, and leukocyte rolling. Soluble guanylate cyclase (sGC), the mammalian NO sensor, transduces an NO signal into the classical second messenger cyclic GMP (cGMP). NO binds to the ferrous (Fe(2+)) oxidation state of the sGC heme cofactor and stimulates formation of cGMP several hundred-fold. Oxidation of the sGC heme to the ferric (Fe(3+)) state desensitizes the enzyme to NO. The heme-oxidized state of sGC has emerged as a potential therapeutic target in the treatment of cardiovascular disease. Here, we investigate the molecular mechanism of NO desensitization and find that sGC undergoes a reductive nitrosylation reaction that is coupled to the S-nitrosation of sGC cysteines. We further characterize the kinetics of NO desensitization and find that heme-assisted nitrosothiol formation of β1Cys-78 and β1Cys-122 causes the NO desensitization of ferric sGC. Finally, we provide evidence that the mechanism of reductive nitrosylation is gated by a conformational change of the protein. These results yield insights into the function and dysfunction of sGC in cardiovascular disease.

Indexed as

AlkylationAnimalsCatalytic DomainCysteineGuanylate CyclaseHemeHumansHydroxidesIronKineticsMutant ProteinsNitric OxideNitrosationNucleotidesOxidation-ReductionProtein BindingCysteineGuanylate CyclaseHemehydroxide ionHydroxidesIronMutant ProteinsNitric OxideNucleotidesReceptors, Cytoplasmic and NuclearSoluble Guanylyl CyclaseSulfhydryl Compounds

Identifiers

PMID23093402
PMCPMC3522300
OpenAlexW2064860687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.